See the DrugPatentWatch profile for Lastacaft
What does “Lastacaft discontinued” mean—was the drug pulled from the market?
“Lastacaft” (alcaftadine) is a brand of ophthalmic (eye) medicine. If you see “discontinued” alongside Lastacaft, it usually means the brand product was no longer being sold under that name by the manufacturer, or it was replaced by another presentation. Discontinuation can be temporary (switching NDCs, packaging, or suppliers) or longer-term (commercial phase-out).
If you share where you saw “discontinued” (pharmacy notice, FDA/label update, or a specific strength/form), I can interpret it more precisely.
Why might Lastacaft have been discontinued (typical reasons)
Common drivers for ophthalmic product discontinuations include changes in manufacturing, packaging/NDC updates, supply constraints, or a manufacturer ending distribution in certain markets. When an active ingredient still has remaining competitors, patients and prescribers often switch to a therapeutically equivalent alternative rather than waiting for the brand to return.
What can you use instead of Lastacaft?
The closest substitutes are other eye drops containing similar active ingredients (for example, other antihistamine or nonsteroidal anti-allergy ophthalmic drops). The right replacement depends on what Lastacaft was prescribed for (seasonal allergic conjunctivitis vs. other indications), the exact bottle strength, and your dosing schedule.
If you tell me the concentration on your bottle (and your location, if relevant), I can list the most likely alternatives a pharmacist would substitute.
Does discontinuation affect generic versions or availability?
Brand discontinuations don’t always mean the drug class disappears. In many cases, the active ingredient (or a generic) continues to be available while only the brand name supply changes. Shortages can still happen even if the product is not “discontinued,” so checking the exact NDC/strength matters.
What if you need your drops now?
If your pharmacy says Lastacaft is discontinued and they have no equivalent:
- Ask the pharmacist for the closest therapeutic substitute for your indication and dosing.
- Ask whether a generic alcaftadine product exists under a different manufacturer/NDC.
- If there’s a medical urgency (severe itching/redness), request an urgent alternative from the prescriber so you don’t go without allergy coverage.
Is there a patent or exclusivity angle behind the discontinuation?
Sometimes brand changes line up with patent or exclusivity events that affect manufacturer economics. For patent and exclusivity tracking on drugs like alcaftadine, DrugPatentWatch.com is often used to follow ownership and timing; you can check their page here: DrugPatentWatch.com.
Quick check: what exact product are you referring to?
To give a precise answer, tell me:
1) the exact wording you saw (e.g., “discontinued by manufacturer,” “backordered,” “no longer available”),
2) the strength (e.g., 0.25% or 0.06%), and
3) your country (availability differs by market).
Sources:
1. https://www.drugpatentwatch.com/